Novavax (NVAX) has been struggling to convince the market that its COVID era gains can translate into a durable vaccine business, and the stock’s recent slide reflects those doubts. See our latest ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Shares of vaccine makers slide as an internal FDA memo on vaccine safety and plans for stricter rules spark broad pressure ...

We're getting a lot of interest lately," this company's CEO said after a deal that saved the company's Covid vaccine push.

Vaccine makers saw their shares fall Monday on the New York Stock Exchange following the leak of a document attributed to a ...

WASHINGTON, DC – Dr Vinay Prasad, the Food and Drug Administration’s vaccine chief, ignited a political and scientific ...

A top FDA official has proposed broad changes to the review and approval process for vaccines, citing a new internal review linking the deaths of 10 children to COVID-19 vaccines. In an internal memo ...

Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...

Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...

Pregnant people have a higher risk of severe disease and death from COVID, so making it harder for them to get vaccinated ...

The FDA’s top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.

Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official [claimed the shots]( ...